✦ LIBER ✦

FDA Critical Path Initiatives: Opportunities for Generic Drug Development

✍ Scribed by Robert A. Lionberger

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Drug Development and the FDA's Critical

✍ Woosley, R L; Cossman, J 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 146 KB

Funding for accelerating drug developmen

✍ Owens, Joanna 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 65 KB

Do Off-Label Drug Practices Argue Agains

✍ Daniel B. Klein; Alexander Tabarrok 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB